Home Blog Page 446

Inspira Enterprise Joins the Microsoft Intelligent Security Association

MUMBAI, India, March 24, 2026 /PRNewswire/ — Inspira Enterprise, a global cybersecurity services provider, today announced it has become a member of the Microsoft Intelligent Security Association (MISA), an ecosystem of software development companies and security services partners that have integrated their solutions with Microsoft Security technology to better defend their mutual customers against a world of increasing cyber threats.

This milestone reiterates Inspira’s ongoing commitment to deliver AI-enabled cybersecurity solutions, safeguarding organizations globally against the ever-evolving cyber threats and contributing to a safer digital world. Inspira’s cybersecurity services integrate with the Microsoft Security product portfolio, including Microsoft Defender, Microsoft Purview, Microsoft Intune, Microsoft Entra, and Microsoft Sentinel. By working together with Microsoft through the MISA ecosystem, Inspira aims to help enterprises improve their ability to detect and respond to evolving cyber threats while enhancing security resilience at scale. Organizations can benefit from intelligent automation, real-time threat intelligence, and security operations capabilities that support faster response and improved protection across complex digital environments.

Commenting on this milestone, Chetan Jain, Managing Director, Inspira Enterprise, said, “Joining the Microsoft Intelligent Security Association is an important step in our mission to deliver advanced AI-driven cybersecurity solutions. Being part of this ecosystem highlights our commitment to aligning our capabilities with Microsoft Security technologies to help organizations strengthen their cyber defenses and respond effectively to emerging threats. By working closely within the MISA community, we aim to empower enterprises with intelligent and scalable security capabilities that support resilient digital transformation.”

“The Microsoft Intelligent Security Association has grown into a vibrant ecosystem comprised of the most reliable and trusted security vendors across the globe,” said Maria Thomson, Director, Microsoft Intelligent Security Association. “Our members, like Inspira Enterprise, share Microsoft’s commitment to collaboration within the cybersecurity community to improve our customers’ ability to predict, detect, and respond to security threats faster.”

Established in 2018 to bring together Microsoft leaders and security vendors, MISA focuses on collaborating to combat security threats and create a safer environment for all. Its mission is to provide intelligent, industry-leading security solutions that work together to help protect organizations at the speed and scale of AI in an ever-increasing threat landscape.

Partners who are interested in learning more can visit the MISA Website: Microsoft Intelligent Security Association.

GTN completes Asia-Pacific “dual-hub” strategy with Hong Kong SFC licence

Second regulated entity in Asia connects global firms to US$3 trillion in regional liquidity and grants local partners access to worldwide markets

HONG KONG, March 24, 2026 /PRNewswire/ — GTN, the global fintech powering limitless investment, today announced it has secured a Type 1 licence from the Securities and Futures Commission (SFC) in Hong Kong. This latest licence upgrades GTN’s Asia-Pacific operation with a dedicated local team in Hong Kong and connects global firms to US$3 trillion in capital flows between China and the rest of the world. Hong Kong becomes GTN’s sixth regulatory-licensed subsidiary alongside the UK, US, Singapore, UAE, and South Africa.

“GTN has provided access to Hong Kong and China markets across its network for several years and has witnessed increasing demand from clients globally to trade in this high-growth region. Securing a regulatory licence and establishing a dedicated team in Hong Kong reflects GTN’s continued commitment to the Greater China region,” said Manjula Jayasinghe, co-founder and Group Chief Executive Officer of GTN. “This milestone enables GTN to facilitate customer order flow from Greater China into global markets, while further enhancing its ability to provide access to Greater China markets for clients across the GTN network.”

Key capabilities for partners:

  • Dedicated Greater China servicing: A local team and direct regulatory mandate to better service Greater China domiciled institutions.
  • Two-way China access: Seamless access to Hong Kong securities and the Stock Connect programme (China-Hong Kong cross-border flows), providing a catalyst for two-way order flow between China and the rest of the world.
  • Fractional trading: Building on its 2025 expansion, GTN now offers regulated fractional trading for HKEX-listed stocks, enabling retail-facing apps to democratise access to high-value Asian equities.
  • Rapid integration: A single integration point for 90+ markets and 8 asset classes, significantly reducing time-to-market.

Recently named “Best API Solution” at the Benzinga Global Fintech Awards 2025 and listed among the World’s Top Fintech Companies 2025 by CNBC and Statista, GTN continues to expand its regulatory footprint.

About GTN

GTN is the global fintech infrastructure powering limitless investment through a unified API-first architecture. By combining cloud-native technology with deep institutional expertise, GTN provides brokers, banks, asset managers, and fintechs with brokerage infrastructure spanning 90+ markets and 8 asset classes through a single API, enabling partners to create the next generation of investing and trading experiences. From fractional trading and micro-portfolios, including $1 fractional bonds, to full-service brokerage, GTN automates the investment lifecycle from digital onboarding to post-trade settlement. As a single counterparty, GTN reduces technical and regulatory burdens, enabling investment banks, brokerage firms, and wealth management firms to scale without building technology from scratch.

With over 600 professionals in 14 countries and more than 450 clients worldwide, we’re united by one mission: transforming the accessibility of investment and trading opportunities for all. Regulated across six jurisdictions (FCA, DFSA, MAS, FINRA, FSCA, SFC), GTN is backed by strategic investors including IFC (World Bank Group) and SBI Ventures Singapore. Learn more at www.gtngroup.com or follow us on LinkedIn.

The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China

  • 73% of participants achieved Q16W dosing interval; Furthermore, nearly 60% of the participants held the potential to extend the dosing interval to Q20W.

SAN FRANCISCO and SUZHOU, China, March 24, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announces that the Phase 3 clinical study (STAR) of efdamrofusp alfa injection (recombinant human vascular endothelial growth factor receptor [VEGFR]/human complement receptor 1 [CR1] fusion protein, R&D code: IBI302) in the Chinese patients with neovascular age-related macular degeneration (nAMD) has met the 52-week primary endpoint. Efdamrofusp alfa demonstrated non-inferiority to aflibercept in vision improvement, while also showing the clinical advantage of extended 16-week dosing intervals and the potential to reduce the risk of macular atrophy (MA).

STAR (NCT05972473) is a Phase 3 clinical study evaluating the efficacy and safety of IB302 8 mg in Chinese participants with nAMD. A total of 600 participants were randomized in a 1:1 ratio to the IBI302 8 mg group and the aflibercept 2 mg group. Both groups received 3 loading doses administered every 4 weeks. After the completion of the loading doses, participants in the IBI302 8 mg group were administered at Q16W, Q12W, or Q8W intervals based on the disease activity assessment at Weeks 16 and 20. Participants in the aflibercept 2 mg group completed the subsequent treatment at Q8W intervals. The study lasts for 100 weeks, and the primary endpoint is the change from baseline in the best corrected visual acuity (BCVA) of the study eye at Week 52. The randomization stratification factors in this study were: the presence or absence of Type 2 choroidal neovascularization (CNV) on optical coherence tomography (OCT) in the study eye, and whether the study eye had previously received anti-VEGF treatment.

The study enrolled 600 participants (including 65% treatment-naïve participants) with a baseline mean BCVA of 58.1 ETDRS letters and a baseline mean central subfield thickness (CST) of 420.75 μm.

The study results showed that in nAMD patients receiving IBI302 8 mg,

  • Visual acuity improvement non-inferior to aflibercept: The study met the primary endpoint. At Week 52, the least squares mean estimate (SE) of the mean BCVA change from baseline in the IBI302 8 mg and aflibercept 2 mg groups was 10.37 (0.547) and 10.11 (0.545) ETDRS letters, respectively.
  • Extension of dosing interval: Approximately 86% of participants in the IBI302 8 mg group achieved a dosing interval of Q12W or above during the maintenance period; 72.8% of participants achieved a dosing interval of Q16W. At Week 52, approximately 95% of the participants receiving the Q12/16W dosing maintained their interval without requiring retreatment. Furthermore, 56.3% of the participants showed no disease activity at Week 24, demonstrating the potential to extend the dosing interval to Q20W.

Table 1. Dosing intervals in Phase 3 trials of efdamrofusp alfa and faricimab (cross-trial indirect comparison)

Efdamrofusp alfa

Faricimab[i]

Dosing interval

STAR

TENAYA

LUCERNE

≥Q12W (%)

86.2

79.7

77.8

Q16W (%)

72.8

45.7

44.9

  • Improvement in anatomical efficacy endpoints: The proportion of participants with no intraretinal fluid and no subretinal fluid in the fovea at Week 16 was comparable between the two groups, and the improvements from baseline in the change in CST from baseline and other anatomical endpoints were similar at Week 52.
  • Potential to inhibit macular atrophy (MA): At Week 52, the incidence of MA in the IBI302 8 mg group and aflibercept 2 mg group was 1.5% and 2.9%, respectively. The incidence of MA after IBI302 treatment was 50% lower than that in the aflibercept group, and the trend was consistent with the results of Phase 2 studies, suggesting that IBI302 has the potential to inhibit MA.
  • Favorable safety: The overall incidence of AEs in the IBI302 8 mg group were comparable to those in the aflibercept 2 mg group. Most ocular adverse events were mild to moderate and resolved after observation or routine management.

The follow-up of this study is still ongoing, and the complete data will be published in future academic conferences or peer-reviewed academic journals.

Professor Xiaodong Sun, Principal Investigator of the Study, Director of the Eye Center, Deputy Director of National Center for Clinical Ophthalmology, Deputy Director of Shanghai General Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, stated: ” As the Principal Investigator, I am delighted to witness the outstanding performance of IBI302 in the STAR study. Although anti-VEGF agents are the first-line therapy for nAMD, the requirement for frequent intravitreal injections and follow-up visits severely compromises patient adherence and quality of life. A key direction in current drug development is exploring multi-target therapeutic strategies and achieving extended dosing intervals to alleviate the treatment burden on patients. As the world’s first innovative anti-VEGF/anti-complement dual-target molecule, IBI302 met the primary endpoint in the Phase 3 STAR study, demonstrating non-inferiority to aflibercept in vision improvement (an average gain of approximately 10.37 letters). Furthermore, most participants were able to achieve a personalized dosing interval of every 12 weeks or longer. Notably, over 70% of these patients could maintain a 16-week dosing interval, significantly reducing the number of injections. This is the first domestically developed novel anti-VEGF fusion protein for ophthalmic use in China to demonstrate the capability of a 16-week dosing interval in a Phase 3 study. We also observed the potential of IBI302 in reducing the incidence of new-onset macular atrophy. We look forward to the timely regulatory approval of this innovative therapy, bringing an alternative treatment option to nAMD patients in China and worldwide. The 2-year results will also be continuously observed to explore the effect on MA inhibition”

Dr. Lei Qian, Chief R&D Officer of General Biomedicine of Innovent, stated, “We are delighted that our innovative ophthalmic drug candidate, efdamrofusp alfa, has achieved a breakthrough in the Phase 3 STAR study. Efdamrofusp alfa demonstrated vision improvement comparable to aflibercept and enabled over 70% of participants to maintain a personalized dosing interval of every 16 weeks, significantly alleviating the treatment burden on patients. Concurrently, the study observed that efdamrofusp holds a potential advantage in inhibiting macular atrophy. These encouraging results lay a solid foundation for subsequent development. We will actively prepare to submit a New Drug Application (NDA), striving to provide a more convenient, patient-friendly, and highly efficacious treatment option for nAMD patients as early as possible. Meanwhile, we will comprehensively advance the lifecycle management and strategic layout of our ophthalmic products, focusing on therapies with a faster onset of action, more durable efficacy, and superior long-term treatment benefits (such as lowering the incidence of macular atrophy and achieving a more complete resolution of retinal edema). Our goal is to bring a greater number of high-quality, innovative ophthalmic drugs to the vast population of patients with nAMD and other fundus diseases.”

About Efdamrofusp Alfa (IBI302)

IBI302 is a recombinant fully human bispecific fusion protein of Innovent Biologics with global proprietary rights. The N- terminal is a VEGF domain that can bind to the VEGF family, block VEGF-mediated signaling pathway, inhibit vascular epithelium proliferation and angiogenesis, and improve vasopermeability and reduce leakage. The C- terminal of IBI302 is the complement binding domain that can inhibit the activation of the classic pathway and alternative pathway of complement through the specific binding of C3b and C4b, and reduce the inflammatory response mediated by the complement. IBI302 may exert its therapeutic effect by inhibiting both VEGF-mediated angiogenesis and complement activation pathways.

About Innovent Biologics

Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 18 products in the market. It has 5 assets in Phase 3 or pivotal clinical trials and 14 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.

Guided by the motto, “Start with Integrity, Succeed through Action” Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.

Statement:

Innovent does not recommend the use of any unapproved drugs/indications.

Forward-Looking Statements

This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Innovent, are intended to identify certain of such forward-looking statements. Innovent does not intend to update these forward-looking statements regularly.

These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of Innovent with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond Innovent’s control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, Innovent’s competitive environment and political, economic, legal and social conditions.

Innovent, the Directors and the employees of Innovent assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect.

Reference:

[i] Heier, Jeffrey S et al. Lancet (London, England) vol. 399,10326 (2022): 729-740.

 

WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus

TOMASZÓW MAZOWIECKI, Poland, March 24, 2026 /PRNewswire/ — A new hyperscale data center campus with a target capacity of 3.2 GW will be developed in Lublewo, in the municipality of Choczewo in northern Poland’s Pomerania region. The project, named Baltic Data Center Campus, is being developed by WBS Power S.A., which has already secured grid connection conditions for the full 3.2 GW capacity.

Visualization of the data center in the municipality of Choczewo
Visualization of the data center in the municipality of Choczewo

“This will be the largest project of its kind in Poland and one of the largest in Europe,” says Maciej Marcjanik, CEO of WBS Power.

WBS Power has taken a strategic step into the hyperscale data center sector, positioning itself as an energy infrastructure provider for AI. The company is responsible for designing, integrating and delivering large-scale, stable and low-emission energy infrastructure that will form the foundation for the development of AI, HPC and cloud infrastructure. 

“This is a natural step in our growth strategy, enabling us to leverage the expertise and market experience we have developed over many years. We are building the infrastructure that will underpin the next phase of the global digital transformation,” says Hubert Bojdo, CFO of WBS Power.

Preparations for the project have taken several months and included the development of the investment concept, the selection of an optimal location and the securing of suitable plot for the development. The chosen site allows the project to scale flexibly across different technological configurations while ensuring access to sufficient power sources. The company is now moving into the next phase of the project. The campus will be built in four phases, each with a planned capacity of 800 MW. Each phase will include:

  • dedicated energy infrastructure for AI workloads,
  • integration with renewable energy sources and battery energy storage systems (BESS),
  • solutions meeting the highest ESG, energy efficiency and energy security standards,
  • platforms designed to support cooperation with global hyperscalers and cloud providers.

Preparatory work for all four phases is expected to be completed by the end of 2027, with the first data center planned to become operational around 2028–2029.

“The rapid development of AI is driving demand for hyperscale data centers supported by advanced infrastructure and reliable access to large volumes of power. The integration of renewable energy and energy storage with digital infrastructure will be a key pillar of competitiveness for next-generation hyperscale projects,” says Maciej Marcjanik.

The Baltic Data Center Campus will be located near one of the largest power substations in Poland. The power supplied to the campus will come from conventional sources complemented by renewable energy and, in the longer term, also nuclear power.

“The digital revolution requires infrastructure on an entirely new scale. We selected the location for the Baltic Data Center Campus very carefully, ensuring access to large power capacities, a diversified energy mix already in place today, and the long-term prospect of stable supply supported by future nuclear generation,” adds Hubert Bojdo.

The Baltic Data Center Campus is not the first project of this type developed by WBS Power. The company is also advancing the Finsterwalde Data Center project in Germany, with capacity of 500 MW, designed in response to growing demand in the German market for hyperscale data centers efficiently integrated with the energy system.

WBS Power brings more than 15 years of experience in developing energy infrastructure, including renewable energy and BESS projects, high-voltage grid infrastructure and powered-land developments.

The company’s activity in Poland and Germany reflects a broader trend of building a new European AI infrastructure landscape.

“We are proud that a Polish company can contribute to Europe’s energy and digital transformation, strengthening its economic competitiveness and technological sovereignty,” concludes Maciej Marcjanik.

CONTACT: Pola Królak, p.krolak@wbspower.com 

 

Manhattan Associates Announced ABA100® Winner for Supply Chain Innovation at Australian Business Awards

SYDNEY, March 24, 2026 /PRNewswire/ — Manhattan Associates Inc. (NASDAQ: MANH), has been recognised as an innovation leader, winning the Supply Chain Innovation category at the ABA100® Business Awards.

The award recognises Manhattan Active® Warehouse Management, part of the Manhattan Active® Supply Chain suite, for its continued advancement of intelligent, cloud-native warehouse operations and its expanding use of AI-driven capabilities to improve speed, accuracy and resilience across supply chains.

The ABA100® Supply Chain Innovation Award celebrates organisations delivering measurable innovation in logistics, distribution and supply chain execution. Manhattan Active® Warehouse Management was recognised for its ability to dynamically adapt to operational change, its highly configurable user experience and its continuous delivery model, which enables customers to access new functionality through regular updates without disruptive upgrades.

Built as a true cloud-native platform, Manhattan Active® Warehouse Management supports real-time visibility and coordination across inventory, labour, automation and storage environments. In recent releases, the solution has expanded its use of embedded intelligence and AI to support smarter decision-making on the warehouse floor, including enhanced demand responsiveness, improved task prioritisation and greater orchestration across increasingly complex fulfilment networks.

These capabilities help organisations respond more effectively to labour constraints, rising customer expectations and the growing volume of omnichannel orders, while maintaining compliance and operational consistency.

“Winning the ABA100® Supply Chain Innovation Award is a strong validation of our continued investment in intelligent, cloud-first supply chain technology,” said Raghav Sibal, Vice President, APAC at Manhattan Associates. “Manhattan Active® Warehouse Management is designed to evolve alongside our customers’ operations, with AI-driven insights and continuous innovation that help organisations move faster, operate smarter and scale with confidence.”

Sibal added that the platform’s architecture allows customers to adopt new capabilities as their needs mature, without the disruption traditionally associated with upgrades. “Our customers are navigating constant change, from peak volatility to shifting consumer expectations. Having a platform that can continuously adapt and introduce new intelligence over time is now critical.”

As supply chains become more interconnected and digitally driven, Manhattan Associates continues to invest in unified, cloud-based solutions that bring together physical operations and digital commerce. The company’s ongoing innovation roadmap focuses on using AI and automation to simplify complexity, improve execution and deliver more responsive, resilient supply chains.

The ABA100® Australian Business Awards are among the country’s most respected business accolades, recognising excellence, innovation and leadership across Australian and international organisations operating in the local market.

-ends-

ABOUT MANHATTAN ASSOCIATES

Manhattan Associates is a global technology leader in supply chain and omnichannel commerce. We unite information across the enterprise, converging front-end sales with back-end supply chain execution. Our software, platform technology and unmatched experience help drive both top-line growth and bottom-line profitability for our customers.

Manhattan Associates designs, builds, and delivers leading edge cloud and on-premises solutions so that across the store, through your network or from your fulfilment centre, you are ready to reap the rewards of the omnichannel marketplace. For more information, please visit www.manh.com

ABOUT ABA100® BUSINESS AWARDS

The Australian Business Awards are an international, all-encompassing awards program honouring organisations that demonstrate the core values of business excellence, product excellence, sustainability and commercial success in their respective industries. Conducted annually and currently in their inauguration, the Awards honour the world’s industry leaders through the acknowledgment of innovative business processes, product development, enterprise, sustainability and overall business success. The Awards also recognise the important social and environmental contributions made by organisations through excellence of service, commitment to their customers, philanthropic ideals, ethical behaviour and environmental sustainability.

AiPPT.com Enhances Its AI Image Generator with Nano Banana 2 to Support Smarter Slide

SINGAPORE, March 24, 2026 /PRNewswire/ — AiPPT.com announced an update to its built-in AI image generator with the addition of the advanced model Nano Banana 2. The update gives users more ways to create visuals that fit their slides while keeping the design process inside the presentation editor.

AiPPT.com works as a modern AI presentation maker that combines writing, layout creation, and media generation in one workspace. The new model strengthens that experience by helping users generate images that match slide themes without leaving the editor.

Expanding Image Generation Options

This presentation creation tool already supports several AI image systems. Users can still access earlier models from the Nano Banana family, including Nano Banana and Nano Banana Pro. AiPPT.com also connects to other popular models such as Flux models, Imagen models, and Seedream 4.0.

Nano Banana 2 expands this collection and improves prompt understanding. The model produces visuals that suit many presentation scenarios. Teachers may create diagrams. Marketers may produce concept illustrations. Creative scenes can also be generated through short written prompts.

A Broader AI Presentation Environment

Nano Banana 2 joins a larger ecosystem inside AiPPT.com. Users can generate a presentation from prompts, documents, and images. A unique feature even lets them download PPT from links: simply enter a webpage URL to generate a clear, editable outline, turn it into a complete slide deck, and save it.

Users also gain access to a large design library. The free PPT template library features over 200,000 slide templates with diverse themes, supporting business reports, academic presentations, marketing materials, and training slides.

More information about AiPPT.com appears on the official page.

About AiPPT.com

AiPPT.com is an AI-powered presentation maker designed to help users create professional slides quickly and easily. With advanced AI generation, AiPPT.com turns topics, documents, or web content into complete slide decks in minutes. The platform offers AI outlines, smart layouts, image generation, chart tools, and thousands of templates, helping users build presentations for business, education, and everyday communication.

Media Contact:
Company Name: PIXELBLOOM PTE. LTD.
Email: support@aippt.com
Website: https://www.aippt.com/

Oracle Launches AI Customer Excellence Centre to Drive Innovation Across Australia and Oceania

Sydney-based Oracle AI Customer Excellence Centre will serve as a regional hub to help organisations adopt the latest AI innovations and accelerate business transformation

SYDNEY, March 24, 2026 /PRNewswire/ — Oracle AI World Tour — Oracle today announced the launch of its AI Customer Excellence Centre in Sydney to help organisations keep pace with rapid AI advancements. The Oracle AI Customer Excellence Centre (AI CEC) will serve as a hub for innovation and collaboration, bringing together leaders to drive AI adoption and success across Australia and Oceania.

“AI will change everything and it will fuel the next wave of opportunity and growth,” said Stephen Bovis, regional managing director, Australia and New Zealand, Oracle. “The Oracle AI Customer Excellence Centre reflects Oracle’s commitment to helping customers, partners, and developers across Australia and Oceania innovate faster using cutting-edge cloud and AI technologies. It will help build the skills and ecosystem needed to support Australia’s digital economy by enabling organisations of all sizes to experiment, learn, and turn innovation into real-world impact.”

The Oracle AI CEC builds on Oracle’s longstanding commitment to supporting governments and enterprises across Australia and Oceania. Through strategic ecosystem partnerships and as part of a global network of innovation centres, these facilities enable customers to design architect, and validate solutions in secured, scalable environments. The Oracle AI CEC provides access to Oracle and third-party technologies, along with flexible deployment options through Oracle Cloud Infrastructure (OCI) to help organisations reduce complexity, accelerate decision-making, and speed time to market.

Supported by a dedicated team of Oracle experts and a network of partners, the Oracle AI CEC is designed to help organisations train teams, test innovations in secured cloud environments, and gain the knowledge needed to transform critical business operations. Benefits of the Oracle AI CEC include:

  • Training: Provides organisations access to training and certifications on the latest cloud and AI technologies led by Oracle University and ecosystem partners.
  • Experimentation: Enables organisations to test early-stage AI innovations in secured cloud environments. Using Oracle Cloud Infrastructure, organisations can explore agentic AI, AI-powered analytics, generative AI, and machine learning across multiple industries, including public sector, healthcare, financial services, and telecommunications.
  • Transformation: Enables organisations to conduct proof-of-concept projects and lay the foundation for full-scale implementation by allowing them to pilot AI initiatives to test their feasibility and potential benefits.
  • Rapid Implementation: Enables organisations to quickly adopt new predictive, generative, and agentic AI features embedded in finance, HR, supply chain, sales, service, and marketing workflows. With the powerful AI capabilities embedded across Oracle Fusion Cloud Applications Suite, organisations can help increase productivity, reduce costs, expand insights, and improve the employee and customer experience.

Analysts and Customers on the Launch of the Oracle AI Centre of Excellence Sydney
“Artificial intelligence is fuelling unprecedented global demand for cloud infrastructure, data platforms and storage. ADAPT’s latest Edge research shows Australian organisations are already experiencing a 23% surge in compute demand, with a further 26% growth expected in the coming year as AI moves from pilots to production. As spending rises, boards and leadership teams want clear proof of AI’s financial impact. With funding constraints and competing priorities still major barriers, technology leaders are under pressure to demonstrate measurable returns. Centres of Excellence, such as the one being launched in Sydney by Oracle, could help accelerate the shift from AI experimentation to real business value while strengthening Australia’s innovation capability,” said Matt Boon, senior research director, ADAPT.

“Access to a local Centre of Excellence gives us a practical environment to experiment, learn, and validate AI solutions in real-world conditions before committing to broader deployment,” said Ryan Klose, executive general manager, chief information officer, Royal Flying Doctor Services. “It’s not just a showcase of what AI can do, it’s a place to reimagine what’s possible for our organisation. With the support of Oracle’s technology and partner ecosystem, we can reduce risk, accelerate time-to-value, and ensure the AI initiatives we scale are grounded in real operational needs and deliver measurable impact.” 

Oracle continues to work with industry, governments and partners to promote responsible, secure, and trustworthy AI adoption.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Oracle AI World Tour
Oracle AI World Tour is where customers and partners discover the latest product and technology innovations, see how AI is being applied across industries, and connect with experts and peers. Attendees will gain practical tips and insights to drive immediate impact within their organisations and explore how Oracle is helping unlock the full potential of cloud and AI. Join the event to see new capabilities in action and hear from thought leaders and industry movers. Register now at oracle.com/ai-world tour or follow the news and conversation at oracle.com/news and linkedin.com/company/oracle.

Trademarks
Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

These Are The Official Best Workplaces In The Philippines For 2026

MANILLA, Philippines, March 24, 2026 /PRNewswire/ — Great Place To Work® ASEAN & ANZ has announced the annual Best Workplaces in The Philippines 2026.

This year’s recognition is built on insights from 241,285 employees, representing the voices of 450,074 workers all across The Philippines, making it one of the most comprehensive workplace culture studies in the country.

“The Philippines has always had an extraordinary relationship with people. We have a culture rooted in community, in bayanihan, and in the belief that everyone deserves to be valued. The Philippines today is also at an exciting inflection point, with a young, dynamic, and deeply committed workforce ready to compete on the world stage.”

“The organizations we recognize are proving that when trust is placed at the heart of a workplace, Filipino talent can lead. These organizations are setting the benchmark of trust and inclusion which will be the foundation of business leadership for the next generation.”
 
– General Manager of Great Place To Work Philippines, Charles Plumley.

The list recognises 55 organisations across Small, Medium and Large categories that have demonstrated exceptional workplace culture and consistently delivered a high-trust employee experience.  Best Workplaces™ in The Philippines 2026

  • Synchrony(Large category: 1,000 or more employees)
  • Hilton(Medium category: 100–999 employees)
  • AbbVie Sdn Bhd(Small category: 30–99 employees)

Discover the full list of Best Workplaces in The Philippines 2026 here 

“We are grateful to be recognized by Great Place to Work as one of the Philippines’ Best Workplaces for seven years running, which underscores our commitment to a supportive, collaborative, and high-performing environment. Our people-first culture centers on growth, well-being, and meaningful work. We listen, learn, and act, building trust and accountability so every employee has the support and opportunity to thrive.” Gaurav Sehgal, Senior Vice President, HR, Asia Synchrony

We are super excited to be ranked among the Philippines Best Workplaces for the fourth consecutive year! Taking part in this list is a strong validation of our efforts in continuously reassessing and improving everyone’s experience in Kollab. This award is a reminder for us to continue looking for ways to improve our people-focused culture.” – Herald Uy, CEO, Kollab Herald Uy

“Being named a Best Workplace tells the world that we are living up to our name. Carelon was built on the promise of total and complete care and that commitment shapes how we build our workplace, how we serve our partners, and how we show up for the communities around us. Over the past few years, we have grown into a global capability center defined by innovation, advanced technology, and a deep commitment to inclusion and nation-building in the Philippines.” – Nicki Agcaoili, VP & Chief Country Executive, Carelon Global Solutions Philippines

Rigorous, Employee-First Methodology

The Best Workplaces in The Philippines 2026 list is determined using the Great Place To Work Trust Index™ Survey, the global standard for measuring workplace culture. Rankings are based entirely on employee feedback about both the quality and consistency of their experience across an organization. Survey responses are analyzed across different demographic groups and roles, with workplaces that earn enough points becoming Great Place To Work Certified, and the best receiving recognition on a globally recognized Best Workplaces List.

“One of the distinguishing factors of Great Place To Work is that our model is built on the idea of a great place to work for all, the ideal of inclusiveness. As the Philippines builds its next-generation workforce, helping organizations scale and amplify a culture of trust, regardless of background or where people come from, is foundational.” – Evelyn Kwek, Managing Director, Great Place To Work® ASEAN & ANZ

MEDIA CONTACT 
Alice Williams

Email: alice.williams@greatplacetowork.com  
Follow Great Place To Work on LinkedIn, Instagram or visit greatplacetowork.com.ph